Si-Bone SIBN
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Si-Bone (SIBN) Core Market Data and Business Metrics
Latest Closing Price
$14.36Price-Earnings Ratio
-19.15Total Outstanding Shares
42.45 Million SharesDividend
No dividendSIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
NASDAQHeadquarters
471 El Camino Real, Suite 101, Santa Clara, CA, 95050
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
---|---|---|---|
398,504 Shares | 4.44 | 3/14/2025 | 1,771,232 Shares |
670,467 Shares | 1.88 | 2/28/2025 | 1,261,829 Shares |
254,500 Shares | 4.22 | 2/14/2025 | 1,073,766 Shares |
285,915 Shares | 3.56 | 1/31/2025 | 1,016,670 Shares |
350,482 Shares | 3.22 | 1/15/2025 | 1,129,439 Shares |
305,201 Shares | 3.68 | 12/31/2024 | 1,123,812 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Net Cash Flow From Investing Activities, Continuing | $12.62 Million |
Net Cash Flow From Operating Activities | $-12.43 Million |
Exchange Gains/Losses | $-479,000 |
Net Cash Flow From Operating Activities, Continuing | $-12.43 Million |
Net Cash Flow | $1.68 Million |
Net Cash Flow From Financing Activities | $1.96 Million |
Income Statement
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Preferred Stock Dividends And Other Adjustments | $0 |
Net Income/Loss | $-30.91 Million |
Income Tax Expense/Benefit | $6.01 Million |
Net Income/Loss Attributable To Parent | $-30.91 Million |
Other Operating Expenses | $150.81 Million |
Income/Loss From Continuing Operations After Tax | $-30.91 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Comprehensive Income/Loss Attributable To Parent | $-31.00 Million |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Other Comprehensive Income/Loss | $-31.00 Million |
Comprehensive Income/Loss | $-31.00 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Other Current Liabilities | $6.73 Million |
Long-term Debt | $35.45 Million |
Current Assets | $207.78 Million |
Current Liabilities | $27.13 Million |
Equity Attributable To Noncontrolling Interest | $0 |
Noncurrent Assets | $22.66 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |